| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.7M | +112.5% |
| Cost of Revenue | $5.9M | +71.2% |
| Gross Profit | $2.7M | +343.9% |
| R&D Expense | $78K | -24.3% |
| SG&A Expense | $6.2M | +55.9% |
| Operating Income | -$3.6M | -2.2% |
| Pre-tax Income | -$3.5M | -8.6% |
| Net Income | -$3.3M | -3.9% |
| EPS (Basic) | -$0.50 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $933K | +47.4% |
| Inventory | $1.8M | +32.8% |
| Current Assets | $5.1M | +1.2% |
| Total Assets | $11.0M | +10.3% |
| Current Liabilities | $2.5M | -3.1% |
| Long-term Debt | $685K | +15.5% |
| Total Liabilities | $4.9M | +2.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -19.5% |
| Capital Expenditures | $443K | -36.4% |
| Investing Cash Flow | -$775K | -117.4% |
| Financing Cash Flow | $3.7M | +889.2% |
| Free Cash Flow | -$4.3M | -9.6% |
| +10.7% |
| EPS (Diluted) | -$0.50 | +10.7% |
| Stockholders' Equity |
| $5.8M |
| +22.5% |